Comments*

 
  • Life Sciences & Biomedical Research

  • Events 

    Monday, October 3, 2016 | 1:30 PM - 4:30 PM

    Genome Integrity Discussion Group

    Speakers: Marcin Imielinski (Weill Cornell Medicine), Christopher Lima (Memorial Sloan Kettering Cancer Center), Barry Sleckman (Weill Cornell Medicine), Alexandra Zidovska (New York University)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

    Friday, October 7, 2016 | 9:00 AM - 5:00 PM

    Advances in the Neurobiology of Mental Illness

    Mental illness causes debilitating consequences on quality of life for individuals, families, and society. This symposium explores avenues for translating these discoveries about the neurobiology of a spectrum of mental illnesses into new treatments.

    Tuesday, October 25, 2016 | 9:00 AM - 5:00 PM

    Emerging Paradigms in Drug Discovery & Chemical Biology

    Speakers: Marcus Bantscheff (Cellzome/GSK), Benjamin F Cravatt (The Scripps Research Institute), Craig Crews (Yale University), Howard Hang (The Rockefeller University), Ruth Nussinov (National Cancer Institute), Brian Raymer (Pfizer), Bryan Roth (University of North Carolina), Eranthie Weerapana (Boston College)

    Chemical Biology is changing the face of drug discovery. This symposium will highlight recent developments in the field, featuring examples from neurobiology and cancer, the ubiquitin proteasome system, GPCRs, and protein lipidation.

    Thursday, November 3, 2016 | 9:00 AM - 5:00 PM

    Microbial Influences in Cardio–Metabolic Diseases

    Speakers: Henrik Bjørn Nielsen (Clinical-Microbiomics A/S), Martin J. Blaser (New York University Langone Medical Center), Patrice D. Cani (Louvain Drug Research Institute, Metabolism and Nutrition), Rachel Carmody (Harvard University), Stanley L. Hazen (Cleveland Clinic), Gerald I. Shulman (Yale University School of Medicine), Marion Soto (Joslin Diabetes Center, Harvard Medical School), and Dan Winer (University of Toronto)

    The microbiome is emerging as an important regulator of health, and disease well beyond the digestive tract. This symposium will highlight recent research innovations and therapeutic applications from the microbiome with a focus on metabolic disease.

    Wednesday, November 9, 2016 | 8:30 AM - 5:15 PM

    Equivalence of Complex Drug Products: Scientific and Regulatory Challenges

    Keynote Speaker: Lawrence D. Mayer (Jazz Pharmaceuticals)

    Explore approaches for complex drug development and regulation, outstanding challenges in the assessment of complex drug equivalence, consequences for product interchangeability, and compare biological and non-biological complex drug families.

  • Past Events

    Thursday, September 22, 2016 | 8:00 AM - 2:15 PM

    Understanding Autophagy to Enhance Clinical Discovery: The 2016 Dr. Paul Janssen Award Symposium

    Featuring: Yoshinori Ohsumi (Tokyo Institute of Technology)

    The 2016 Dr. Paul Janssen Award Symposium will honor Dr. Yoshinori Ohsumi for his groundbreaking research demonstrating that autophagy is a crucial process in maintaining cellular homeostasis as well as establishing its role in human health.

    September 21 - 23, 2016

    13th Key Symposium 2016: Bioelectronic Medicine — Technology Targeting Molecular Mechanisms

    Featuring: Peder S. Olofsson (Karolinska Institutet) and Kevin J. Tracey (The Feinstein Institute for Medical Research)

    Bioelectronic medicine, a new discipline aimed at interfacing electronics with cells to target molecular mechanisms, is at the epicenter of healthcare, technology, and science. This symposium will advance the technological promise of bioelectronics.

    Friday, September 16, 2016 | 8:30 AM - 6:00 PM

    Big Data, Consumer Technology, and the Obesity Epidemic: Emerging Science and Ethical Considerations

    Speakers: Lori B. Andrews (Chicago-Kent College of Law, Illinois Institute of Technology), Gary Bennett (Duke University), Barbara E. Millen (Millennium Prevention, Inc.), Tooraj Mirshahi (Geisinger Clinic), Satchidananda Panda (SALK Institute), Ruth E. Patterson (University of California San Diego), Michael K. Price (Georgia State University), Karandeep Singh (University of Michigan), and Nicholas Tatonetti (Columbia University)

    Researchers, health professionals, and a growing wellness-conscious public use technology to monitor health status. Big Data harnessed from this technology have created a foundation for focused research targeting obesity, but at what cost?

    Friday, September 9, 2016 | 12:00 PM - 4:00 PM

    Protein Engineering and Protein Therapeutics

    Speakers: Yael David (MSKCC), Shohei Koide (NYU Langone Medical Center), Alexander J. Kasznel (University of Pennsylvania), Jonathan R. Lai (Albert Einstein College of Medicine), Jim Wells (University of California San Francisco), and Manoj Charati (Pfizer)

    This symposium will highlight state-of-the-art technologies in protein and antibody engineering, and antibody-drug conjugates. The implementation of these methods to specific diseases, and unique research tools, will also be discussed.

  • Publications 

    Annals

    Special Issue: MARROW

    Edited by Mone Zaidi (Mount Sinai School of Medicine, New York, New York)

    Original research and review manuscripts covering topics in basic and translational bone and bone marrow biology.

    eBriefing

    Sohn Conference: Pediatric Cancer in a Post-genomic World

    Keynote Speakers: Richard Gilbertson (Cambridge Cancer Centre, University of Cambridge, UK) and Craig B. Thompson (Memorial Sloan Kettering Cancer Center)

    This eBriefing covers the latest research on pediatric cancers.

    eBriefing

    Epigenetics: Cancer and Beyond

    Organizers: Donald McCaffery (Resverlogix Corp.), Norman Wong (Resverlogix Corp.), Sarah Zapotichny (Resverlogix Corp.), George Zavoico (Jones Trading Institutional Services), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)
    Keynote Speaker: Craig B. Thompson (Memorial Sloan Kettering Cancer Center)

    Epigenetic abnormalities contribute to tumorigenesis and various diseases beyond cancer. This eBriefing describes recent progress in validating the therapeutic potential of small molecule inhibitors targeting epigenetic marks.

    Annals

    Special Issue: Annals Reports

    Edited by Annals of the New York Academy of Sciences editorial staff

    This Annals issue presents a meeting report on mobile health technology in clinical trials and five original research articles discussing topics related to β-thalassemia major, Alzheimer's disease, hematopoiesis, hepatosteatosis, and downbeat nystagmus.

    Volume 1375